Djupesland P, Bjurne G, Aanonsen N O, Borchgrevink H M, Mundal R, Høiby E A
Forsvarets Sanitet, Oslo mil/Huseby.
Nord Med. 1990;105(6-7):179-81.
An outline of aspects of meningococcal disease relevant to The Norwegian armed forces during the last years is given. Epidemiological observations are described as well as ongoing trials with the Norwegian serogroup B outer membrane complex vaccine. These trials are parallel to civilian trials in teenagers. In accordance with the new Norwegian civil guidelines for diagnosis and treatment of meningococcal disease stress is laid on early symptoms of the disease and early treatment (drawing of a blood culture and subsequent prompt parenteral penicillin therapy in the camp when probable meningococcal disease is the case and the estimated transportation time to hospital exceeds about 30 min).
本文给出了过去几年中与挪威武装部队相关的脑膜炎球菌病各方面概述。描述了流行病学观察结果以及挪威B群外膜复合物疫苗的正在进行的试验。这些试验与青少年的民用试验并行。根据挪威关于脑膜炎球菌病诊断和治疗的新民用指南，强调了该病的早期症状和早期治疗（在营地抽取血培养样本，当疑似脑膜炎球菌病且预计转运至医院的时间超过约30分钟时，随后立即进行肠胃外青霉素治疗）。
